Cat.#: ACPP-1335
Despition | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide for Immunocompetition, Immunodepletion |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1136 | TYRO3 Blocking Peptide (AC1136) | 250 µg | inquiry |
ACPP-1232 | GPCR GPR15 Blocking Peptide (AC1232) | 250 µg | inquiry |
ACPP-1123 | Recombinant Rat GFAP Protein (AC1123) | 25 µl | inquiry |
ACPP-1667 | Human AGRP Protein (AC1667) | 2 µg | inquiry |
ACPP-1084 | Recombinant Human Autotaxin Protein (Functional) (AC1084) | 10 µg | inquiry |
ACPP-1185 | Mouse FGF 1 Protein (AC1185) | 10 µg | inquiry |
ACPP-1516 | Human Insulin Protein, Yeast (AC1516) | 2 mg | inquiry |
ACPP-1115 | Recombinant Human CD45 Protein (6×His Tag) (AC1115) | 50 µg | inquiry |
ACPP-1686 | Human Acrp30 Protein, HEK (AC1686) | 2 µg | inquiry |
ACPP-1531 | Human CHMP2B Protein (AC1531) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.